1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Phencyclidine: An Update

Phencyclidine: An Update

  1. ThirdEyeFloond
    NIDA Research Monograph, Number 64 [Printed in 1986]

    Table of Contents

    Foreword-----v

    Preface-----vii

    Characterization of Phencyclidine and Sigma Receptor-Binding Sites in Brain-----1
    Andrew L. GundZach, Brian L. Lurgent, and Solomon H. Snyder

    Further Evidence of Phencyclidine/Sigma Opioid Receptor Commonality-----14
    Ratna Sircar and Stephen R. Zukin

    Isolation and Identification of an Endogenous Ligand for the Phencyclidine Receptor-----24
    Debora A. DiMaggio, Patricia C. Contreras, Remi Quirion, and Thomas L. O' Donohue

    ic Phencyclidine (PCP) Selectively Blocks Certain Presynapt Potassium Channels-----37
    Mordecai P. Blaustein, Dieter K. Bartschat, and Roger G. Sorensen

    Involvement of Dopaminergic, Cholinergic, and Glutamatergic Mechanisms in the Actions of Phencyclidine-Like Drugs-----52
    Kenneth M. Johnson and Lawrence D. Snell

    Anticonvulsant Properties of Phencyclidine and Ketamine-----67
    Gary G. Buterbaugh and Hillary B. Michelson

    Agonistic and Antagonistic Effects of PCP-Derivatives and Sigma Opioids in PCP Behavioral and Receptor Assays-----80
    Patricia C. Contreras, Remi Quirion, and Thomas L. O'Donohue

    Electroencephalographic (EEG), Psychopharmacological, and Receptor-Binding Profiles of 'Phencyclinoids'-----94
    Antonia Mattia, Arthur P. Leccese, Karen L. Marquis, Esam E. El-Fakahany and J. Edward Moreton

    Modulation of Phencyclidine (PCP) Pharmacokinetics With PCP-Specific Fab Fragments-----112
    S. Michael Owens and Michael Mayersohn

    Psychopharmacology of Phencyclidine-----127
    Joe Marwah and David K. Pitts

    Discriminative Stimulus Properties of PCP Mimetics-----134
    Ronald G. Browne

    Clinical Implications of Behavioral Pharmacology Research on Phencyclidine-----148
    Robert L. Balster

    Phencyclidine: Changing Abuse Patterns-----163
    Raquel Crider

    PCP and Crime: Just Another Illicit Drug?-----174
    Eric D. Wish

    Neuropsychological Assessment of Phencyclidine Abusers-----190
    James E. Lewis and Robert B. Hordan

    Phencyclidine Intoxication-----209
    Margaret M. McCarron

    Diagnosis and Treatment of Chronic Phencyclidine (PCP) Abuse-----218
    David A. Gorelick, Jeffrey N. Wilkins, and Carl Wong

    Legal Issues Associated With PCP Abuse--The Role of the Forensic Expert-----229
    Steven E. Serner and Richard S. Burns

    The Long-Term Effects on Neurodevelopment in Infants Exposed Prenatally to PCP-----237
    Judy Howard, Vickie Kropenske, and Rachelle Tyler

    Clinical Observations in the Treatment of Adolescent and Young Adult PCP Abusers-----252
    David H. Fram and Nancy Stone